Rates and Discounts
Product Pricing
All patient group respondents get ALL PatientView reports free of charge.
Introducing PatientView’s new guide for pharma: Being Patient centric after a pandemic
Complete package:
Overview + 9 indicators of ‘Being Patient Centric’ analysed, £6,500
Patient-group experiences during the 2020 Covid-19 pandemic
Three reports
| Overall results from 1,720 respondent patient-groups with Case studies |
| Comparing the answers of patient groups from different therapy areas |
| Comparing the answers of patient groups from different countries and regions |
Complete package: £6,500
Corporate reputation of pharma: Patient perspectives
11 years of historical data
- Consistent indexing of individual companies
- Questions defined by patients first
- Global, regional and therapeutic analyses (16 datacuts)
- Opportunities to commission further deep dive into the data
Prices 2021-2022
| Individual report | £8,000 |
| Subscription to all reports | £24,000 |
| Special package on request | Discounts are available on the purchase of multiple reports |
All licences are global
Bring patient -centric
Evidence-based self-evaluation toolkit
- Patient centricity defined by patients
- Structured framework aligned to pharma operations
- Self-assessments, each with circa 100-150 questions
- Deep-dives within specific topics
Prices 2022
| Patient Engagement in R&D (USA) | £7,500 |
| Patient Engagement in R&D (GLOBAL) | £7,500 |
| Drug Treatment Information | £7,500 |
| Discounts: Buy 2 | £12,000 |
Patient-group relations
Insights for effective patient relations
- Mapping the patient movement
- Identifies areas for focused research
- Supports targeted investment
- Can be tailored to identify local/geographic and therapeutic needs
Prices, 2022
| 17 therapy areas analysed | £6,000 |
| 21 country analyses | £6,000 |
| Discounts: Buy 2 | £9,000 |
Global Review of the Patient Movement 2012-2018 free with any purchase
Why PatientView?
- Knowledge of the patient movement
- Researching patient groups since 2000
- Permission-based database of 40,000 patient groups worldwide
- Surveys conducted in 20 languages
Why Patient Groups?
- Experts in patients’ concerns across multiple disease areas
- Knowledge of patients’ issues at a country/local level
- Knowledge of pharmaceutical-industry issues and challenges
- Advocates for better healthcare
- Instrumental in shaping care and raising awareness
- Strong governance and ethics, reliable data
